Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
Key facts
- Where
- New York, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 90 years old?
Source: NCT05810220, who can take part
Where in United States
- NYU Langone HealthNew York, United StatesContact: Mahan AzadpourTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- NYU Langone Health
- Trial code
- NCT05810220
- Record updated
- 29 October 2026
- Original description
This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.Read full original descriptionShow less
This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.
Inclusion: Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlear implants; No diagnosis of any other communicative or cognitive disorder other than hearing impairment. The individual must be able to visit the lab in order to participate in behavioral and electrophysiological experiments; Patients' implant device must have useable electrodes that do not result in uncomfortable or unpleasant non-auditory sensation.
Exclusion: No useable electrodes in their implants; Diagnosed cognitive or communicative disorders (other than hearing impairment); Severe neurological disorders.